Angiodynamics, inc. (ANGO)
CashFlow / Quarterly
Feb'20Nov'19Aug'19May'19Feb'19Nov'18Aug'18May'18Feb'18Nov'17Aug'17May'17Feb'17Nov'16Aug'16May'16Feb'16Nov'15Aug'15May'15Feb'15Nov'14Aug'14May'14Feb'14Nov'13Aug'13May'13Feb'13Nov'12Aug'12May'12Feb'12Nov'11Aug'11May'11Feb'11Nov'10Aug'10
Cash flows from operating activities:
Net income (loss)

-5,709

-2,736

-1,275

58,873

796

2,140

-469

2,102

14,019

249

-35

-12,913

2,887

13,734

1,300

-43,075

594

-334

-775

-934

-4,262

1,338

470

-1,534

4,515

-261

-373

-1,467

-992

1,969

-721

-7,117

-1,768

2,329

1,373

-861

3,811

3,279

1,888

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization

6,440

5,903

5,207

6,722

6,867

6,692

5,599

5,768

5,718

5,884

5,793

6,356

6,169

6,133

6,153

6,826

6,979

7,197

7,113

7,085

8,777

7,299

6,700

7,216

7,243

7,960

5,910

8,656

6,410

6,292

5,869

5,215

3,188

3,141

3,132

3,467

3,128

2,955

3,029

Change in allowance for excess and obsolete inventory

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-266

Stock based compensation

1,772

2,242

1,984

2,130

2,378

2,591

2,150

2,091

2,058

1,966

1,797

1,105

1,693

1,701

1,684

-1,260

1,640

1,234

1,626

1,609

1,488

1,506

1,395

1,480

1,599

1,271

1,152

1,237

997

1,253

1,122

1,054

1,121

1,078

799

1,207

1,148

1,035

1,219

Amortization of acquired inventory basis step-up

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

400

0

3,445

-

-

-

-

-

-

-

-

Tax effect of exercise of stock options and issuance of performance shares

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

72

39

438

-240

838

-68

-38

9

Change in fair value of contingent consideration

419

145

-448

-

609

244

12

-

31

82

105

-

122

-15,951

443

-

-31

306

355

-

-10,044

617

801

-

-4,154

940

733

-

-

-

-

-

-

-

-

-

-

-

-

Gain on contingent consideration for IPR&D Write-off

-872

-559

-175

-

138

505

-10

-

-10,044

-24

-82

-

1,554

505

1,565

-

203

-383

-208

-

-7,823

1,575

2,110

-

545

586

569

-

1,244

2,260

-85

-

-1,305

147

911

-

152

1,410

875

Change in accounts receivable allowances

-13

652

-453

-103

-24

153

-228

214

-315

2

278

292

5

-413

-197

1,022

1,017

229

109

789

314

218

127

184

-31

117

195

308

24

41

-35

72

-159

151

54

-10

18

-76

-5

Fixed and intangible asset impairments and disposals

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-190

190

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Fixed and intangible asset impairments and disposals

26

270

99

-

677

12

0

-

-

-

-

-

78

3,699

45

-

53

402

220

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Write-off of other assets

0

0

593

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other

-97

19

8

0

-12

42

-25

-30

78

-10

567

51

-41

594

-18

-90

-261

248

13

-251

-19

89

0

-180

26

-84

108

-38

-690

616

-45

-871

-314

-109

146

-84

182

-38

-115

Changes in operating assets and liabilities:
Accounts receivable

1,630

2,010

-11,474

-676

785

2,506

562

-2,147

-598

804

-3,103

-1,581

-3,855

-221

-2,822

-639

2,416

1,017

-5,925

1,440

-466

2,746

-5,815

5,118

9,545

1,916

-1,793

2,907

-2,430

1,698

-3,195

2,767

-4,887

5,237

-722

-1,330

2,717

2,049

-6,206

Inventories

4,027

4,856

5,153

-1,274

1,747

194

761

-7,653

2,511

-1,379

781

-3,272

1,027

-1,491

3,049

-10,519

-4,930

-3,449

6,922

-1,828

-6,605

4,894

9,187

2,623

-860

878

3,473

-7,559

-484

-1,084

11,036

1,245

-1,269

-245

1,791

-1,363

-3,570

-520

4,035

Prepaid expenses and other

5,834

2,798

746

363

325

-17

1,200

683

-155

1,323

-620

2,305

747

-401

869

-1,494

-1,359

-464

2,605

-1,149

-1,393

876

2,836

-4,166

1,076

1,507

375

-579

-99

-900

601

718

3,284

1,845

153

321

-1,176

-816

-379

Accounts payable, accrued and other liabilities

-9,169

8,799

-17,633

15,548

-254

3,347

-13,429

2,704

-5,338

2,736

-7,195

20,619

-265

1,335

-2,475

1,085

-2,195

-1,720

-126

174

-290

-5,905

-233

3,967

-589

2,133

1,277

423

-3,273

-49

-6,812

3,125

2,565

2,509

-1,617

3,201

311

1,732

-7,676

Net cash provided by operating activities

-17,837

5,937

-6,534

25,012

8,342

12,959

-8,873

23,771

4,315

10,165

3,036

18,993

14,365

14,947

7,440

18,544

12,394

9,579

4,699

10,249

12,231

-2,147

5,352

9,507

-584

8,458

7,300

11,137

10,000

11,129

-5,614

-900

6,789

2,669

3,044

11,897

10,347

9,888

1,738

Cash flows from investing activities:
Additions to property, plant and equipment

1,742

2,623

1,391

815

887

734

682

744

425

721

501

743

412

1,365

481

431

727

425

743

345

3,515

2,419

5,104

2,169

1,812

4,288

2,903

4,412

2,921

3,819

968

613

821

517

541

985

483

827

662

Acquisition of intangibles

0

200

150

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for acquisitions

10,000

45,760

0

-

0

47,920

37,000

-

0

0

0

-

-

-

-

-

-

-

-

-

754

96

154

-

30

-780

930

-

250

1,258

-858

-

-

-

-

-

-

-

-

Acquisition of businesses, net of cash acquired

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

930

3,239

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from disposal of intangible and other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-1,000

-

-

-

-

Purchases of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

172

4,962

5,291

40,671

35,349

42,303

18,486

21,716

120,209

8,065

Proceeds from sale of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

50

0

303

0

0

9,624

7,365

99,851

24,987

27,715

41,560

18,191

20,010

71,278

14,602

Net cash used in investing activities

-11,742

-48,583

-1,541

168,427

463

-48,654

-37,682

-744

-1,690

-721

-501

-743

-412

-915

-481

-3,681

-2,745

-400

-743

-694

-4,269

-2,515

-5,258

-3,424

-1,817

-4,438

-6,769

-4,412

-11,387

-8,732

2,293

-150,794

-16,705

-8,451

-284

-1,282

-3,455

-49,758

5,875

Cash flows from financing activities:
Repayment of long-term debt

0

0

132,500

1,250

11,250

1,250

1,250

1,250

1,250

1,250

1,250

1,250

17,721

118,910

2,500

5,000

7,500

2,500

1,250

11,250

6,250

1,250

1,250

1,250

1,250

143,750

0

1,875

1,875

1,875

1,875

6,345

70

70

65

65

65

65

65

Deferred financing costs on long-term debt

34

0

741

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of acquisition related contingent consideration

0

0

1,208

-10,200

0

0

2,100

-19,000

0

7,400

2,100

-19,700

0

7,750

2,100

-19,700

0

7,750

2,100

-22,444

0

9,122

2,100

-30,540

5,297

8,350

950

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds (outlays) from exercise of stock options and employee stock purchase plan

594

0

-1,300

8

1,169

149

705

389

822

926

812

429

3,865

3,601

2,803

504

703

-49

1,279

144

3,510

1,144

959

236

1,075

455

678

118

620

-103

579

44

1,062

446

1,804

68

1,294

-132

850

Net cash provided by (used) in financing activities

15,560

0

-135,749

-7,242

-10,081

53,899

-2,645

-861

-428

-7,724

-2,538

-6,567

-14,014

-15,605

-1,797

-4,496

-6,797

-10,299

-2,071

-11,106

-2,740

5,772

-2,391

2,640

-5,472

-10,912

-272

-1,757

-1,255

-1,978

-1,296

141,335

992

-1,728

1,739

105

1,229

-197

785

Effect of exchange rate changes on cash and cash equivalents

-68

244

-168

-260

160

-146

-134

-362

239

-64

659

290

-32

-174

-84

69

49

-152

-8

238

-395

-41

0

0

82

0

4

-22

-55

7

5

51

16

-28

10

7

4

-3

41

Decrease in cash and cash equivalents

-14,087

-42,402

-143,992

185,937

-1,116

18,058

-49,334

21,804

2,436

1,656

656

11,973

-93

-1,747

5,078

10,436

2,901

-1,272

1,877

-1,313

4,827

1,069

-2,297

8,723

-7,791

-6,892

263

4,946

-2,697

426

-4,612

-10,308

-8,908

-7,538

4,509

10,727

8,125

-40,070

8,439

Supplemental disclosure of non-cash investing and financing activities:
Contractual obligations for acquisition of intangibles and business

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-2,721

0

0

4,970

-

-

-

-

-

-

-

-

-

-

-

-

Accrual for capital expenditures incurred during the period

-230

-33

477

-72

-23

-57

38

-39

-3

60

38

-73

77

-30

52

38

-191

117

111

-71

157

54

0

3,770

476

-1,939

2,663

-329

-631

-260

2,769

-

-

-

0

-

-

-

-